News

October 19, 2011— W. L. Gore and Associates announced that the company purchased the assets and intellectual property of now defunct company NMT Medical Inc. The purchase included the data related...

September 27, 2011 — Occlutech announced its CEO, Tor Peters, has obtained a favorable ruling from the district court in Düsseldorf in patent litigation initiated personally against him by St....

August 25, 2011 – Transcatheter structural heart occluder maker Occlutech said this week it closed a 15 million Euro investment in the company to accelerate its device development and bring it to...

June 29, 2011 – For the first time, human blood vessels grown in a laboratory from donor skin cells have been successfully implanted into patients, according to new research presented in the American...
May 16, 2011 - The German Supreme Court (BGH) declared a structural heart occluder patent case to be invalid. In the ruling by the BGH, the court does not see any basis for AGA/St. Jude's claim that...
May 10, 2011 – In a “real-world” test of treatments for an overly thickened heart muscle, the use of alcohol injections to shrink the unwanted tissue appears to be significantly safer and less...

March 4, 2011 - Occlutech GmbH received a favorable court ruling in Stockholm, Sweden in the ongoing patent litigation case with AGA Medical-St. Jude Medical.

November 15, 2010 - A catheter procedure that closes a hole in patients’ hearts appears to be no more effective than drug therapy in preventing recurrent strokes, according to trial results...

November 3, 2010 – The first patient has been enrolled into a study comparing a left atrial appendage (LAA) closure device to warfarin therapy in those with atrial fibrillation. The PREVAIL study...

The first-in-man use of the Coherex WaveCrest left atrial appendage (LAA) occluder system was successfully performed recently in New Zealand, launching the WAVECREST 1 trial to evaluate the device...

October 25, 2010 – The Hague, Netherlands ruled in favor of Occlutech, a transcatheter structural heart occluder device maker, in the ongoing patent litigation with AGA Medical. The lawsuit stems...

St. Jude Medical Inc. said it plans to acquire AGA Medical Holdings Inc. for about $1.3 billion. The purchase will expand St. Jude’s cardiac device offerings with a portfolio of transcatheter...

October 4, 2010 – Germany will reimburse patients who have a left atrial appendage closure procedure in 2011. The 2011 G-DRG (German Diagnosis Related Group) catalog, recently published on the...

September 28, 2010 – The Transcatheter Cardiovascular Therapeutics (TCT) 2010 symposium featured a live case broadcast of a physician implanting a new device to treat refractory angina.

September 23, 2010 – The first consensus document for treating structural heart disease has been published by the Society for Cardiovascular Angiography and Interventions (SCAI).

August 25, 2010 – Alleging infringement of a patent for its transcatheter cardiac septal occluder devices, AGA Medical Holdings Inc. said it filed a lawsuit against W.L. Gore & Associates.

August 25, 2010 – There will be special tracks available for nurses and technologists and for the transcatheter treatment of patent foramen ovale (PFO) during the Transcatheter Cardiovascular...

August 12, 2010 – A 52-year-old male heart failure patient in Krakow, Poland, became the first human to receive the PliCath HF System for an epicardial catheter-based ventricular reconstruction (...

July 9, 2010 – W. L. Gore and Associates announced today that they are confident in the design and anticipated results of the Gore REDUCE Clinical Study, which was designed to test the safety and...

June 28, 2010 – AGA Medical has been denied the right to appeal a decision in a United Kingdom patent case concerning structural heart occluders.